Keywords
How to Cite
Abstract
This is a descriptive study aimed to detect the expression of Ki67 and Her2 tumor markers in cervical tumors. Forty-five formalin fixed paraffin blocks were randomly selected from women samples previously diagnosed as cervical tumors (Thirty-five samples were malignant tumors and ten samples were benign tumors). The paraffin blocks were cut by rotary microtome and stained by immunohistochemical method for detection of Ki67 and Her2. The data obtained was analyzed using SPSS program. The malignant tumors included 29 (83%) samples were squamous cell carcinoma and remaining 6 (17%) samples were adenocarcinoma.
The patient age ranged from 27 to 85 years with mean age of 57 years. From the samples 14 (31%) samples were Ki67 positive (all of them were malignant) and 31 (69%) samples were Ki67 negative (P value <0.05). The results also showed 15 (33%) samples Her2 positive (all of them were malignant) and 30 (67%) samples were Her2 negative (P value <0.05). Regarding malignant tumors 14 (40%) positive samples and 15 (43%) negative samples were squamous cell carcinoma and no positive result was found of Ki67 expression for adenocarcinoma (P value >0.05). And 10 (29%) positive samples and 19 (54%) negative samples of Her2 results were squamous cell carcinoma and 5.0 (14%) positive samples and 1 (3.0%) negative sample of Her2 results were adenocarcinoma (P value >0.05). This study concluded that the expression of Ki67 and Her2 is associated with malignant tumors of the cervix, also concluded that there was significant different between Ki67 and histopathological grade while there were no significant different between Her2 expression and the histopathological grade.
References
- Bultaro T M, Trybulski J, Bailey P and Sandherg-cook J. (2012). Primary Care: A Collaborative Practice, 4th edition, Elservier Health Science, 839.
-Harris R E. (2013). Epidemiology of chronic disease (Global perspective), international edition, Jones &Bartlett, 223.
- Radiation and Isotope center in Khartoum (RICK) and National Cancer Institute of the University of Gezira (NCI- UG) in Wad Madni, Gezira State. (2012).
- Hurt K J, Guile M W, Fox H E, Wallach E E. (2012). The Johns Hopkins Manual of Gynecology and Obstetrics, 4th edition, Lippincott Williams& Wikins, 541.
- Dizon D S, Kychman M L and Disilvestrop. (2009). 100 Questions and Answers about Cervical Cancer, 1st edition, Jones and Bartlett Publisher LIC, 7.
- O'callaghan V. (2011). Understanding Cervical Cancer (Guide for Women with Cancer their Families and friends), 3rd edition 2011, Cancer Council NSW, 25.
- Bancroft JD, Marilyn G. (2008). Theory and practice of histological techniques, 6th ed, Churchill Livingstone, London, 125.
- Ancuta, E, Codrina, A, Cazma G, et al. (2009). Tumor biomarker in cervical cancer: focus on Ki67 proliferation factor and E.cadherin expression, Romanian Journal of Morphology and Embryology, 50 (3): 413-418.
- Pollock, ER. and Ross, C. (2008). Advanced Theory in Surgical Oncology, 1st edition, B C. Decker Inc, 534-535.
- Olsen, J, Christensen, K, Murray, J and Akbom, A. (2012). An Introduction to Epidemiology for Health professional, 1st edition, spring science + businessmedia LLC, 45.
-Rositch, AF, Nowak, RG and Gravitt, PE. (2014). Increase Age and Race-specific Incidence of Cervical Cancer after Correlation for Hysterectomy Prevalence in the United states from 2000-2009, Cancer 1; 120(13):2032-2038.
- Son, SM., Noh, KI, Lee, HC, Park, YJ, Jeong, EH, et al. (2012). Evaluation of p16INk4a, pRb, p53 and Ki-67 expression in cervical squamous neoplasia. Cell Cycle, 5: 6. 13- Gupta, N, Singh, S, Marwah, N, Kumar, S, Chabra, S and Sen, R. (2009). Her2neu Expression in Lesion of Uterine Cervix: is it Reliable and Consistent, Journal of Clinical Oncology, volume 52(4): 482-485.
-Lee, Y and Lee, CK. (2003). Classifification of Multiple cancer types by multiplecategory support vector machines using gene expression data, Bioinformatics 19:1132- 1139.